RecruitingNCT06691971

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

A Pilot Study to Assess Aevice Medical Device for Detection of Wheeze in Pediatric and Adult Populations


Sponsor

Aevice Health Pte. Ltd.

Enrollment

160 participants

Start Date

Jun 29, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.


Eligibility

Min Age: 3 Years

Inclusion Criteria3

  • The subject is willing and/or parents/guardians are able to give informed consent for participation in the study.
  • Male or Female, aged ≥ 3 years.
  • Diagnosed with acute asthma exacerbation by an ED provider.

Exclusion Criteria1

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.

Interventions

DEVICEAeviceMD

The AeviceMD device will be placed on the patient to detect the presence of wheeze and perform auscultation.


Locations(1)

Montefiore Medical Center

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06691971


Related Trials